Atlas Trials

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Clinical trial NCT00003245 · COMPLETED

Trial details

NCT number
NCT00003245
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
1998-02-18
Primary completion
2004-07-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.